High-Fidelity In Vitro Models for Predictive Human Response
Our cutting-edge technology platform seamlessly merges physiological relevance with high-throughput screening capabilities. By integrating advanced Organoid self-assembly, microfluidic Organ-on-a-Chip systems, and interconnected Multi-Organ Models, we deliver in vitro solutions that significantly surpass traditional 2D culture and animal models. We provide a more accurate, physiologically relevant approach for drug screening, toxicology testing, and disease modeling, accelerating your preclinical pipeline with unparalleled human predictability.
Contact Us for a Free Consultation
Core Technology Platforms
Organoids
We leverage the self-organization capacity of induced Pluripotent Stem Cells (iPSCs) or adult stem cells to cultivate complex three-dimensional micro-tissues in vitro. These models possess the characteristic cell types, structural organization, and key physiological functions of native human organs (e.g., brain, gut, liver organoids).
- High physiological relevance and cellular complexity
- Scalable and reproducible models for diverse organ types
- Compatible with drug efficacy, toxicity, and disease studies
Combining microfluidic engineering with cell biology, we utilize polymer chips to establish functional tissue units that precisely mimic the organ's microenvironment. The platform allows for the exact control of fluid flow, mechanical stresses (like breathing motion), and cell-cell/cell-matrix interactions.
- Precise control over microenvironment
- Enables long-term culture and functional assays
- Supports mechanistic studies and high-content analysis
Multi-Organ Systems
Through optimized fluidic connection and integrated control systems, we link two or more different Organ-on-a-Chips (e.g., Liver, Kidney, and Heart chips) to construct an in vitro system that simulates systemic human physiology and inter-organ communication.
- Integrates multiple organ models for comprehensive studies
- Predicts pharmacokinetics, toxicity, and systemic responses
- Facilitates complex disease modeling
Supporting Technologies
3D Bioprinting
Utilizing high-precision bioprinting and custom bio-inks, we are able to accurately and reproducibly construct complex 3D tissue models and organoid scaffolds with a predefined geometrical structure and controlled cell arrangement.
3D Imaging
We employ state-of-the-art systems, including Light-Sheet Microscopy and high-content Confocal Microscopy, to perform non-destructive, rapid, and high-resolution deep imaging of our thick organoid and chip models.
Why Choose Us
Scientific Rigor
Our models are functionally validated against in vivo data, ensuring the highest level of physiological concordance.
Industrial Standard
3D Bioprinting and microfluidics ensure high reproducibility and compatibility with high-throughput screening (HTS) platforms.
Integrated Solutions
We offer an end-to-end service, from model construction and drug testing to comprehensive data analysis.
Expert Support
Our interdisciplinary team of biologists, engineers, and drug discovery specialists provides deep scientific guidance and bespoke services.
Our Model Development Workflow
1. Project Consultation
We define research goals, target organs, and assay needs to determine the optimal model strategy.
2. Model Design & Cell Preparation
Platforms (organoid, organ-on-chip, or multi-organ) are selected, and validated human cells are sourced and QC-tested.
3. Model Construction
Organoids are grown or chips are seeded and assembled under controlled microenvironment conditions.
4. Functional Validation
Key physiological and structural features are verified to ensure model quality and reproducibility.
5. Study Execution & Reporting
Experiments are performed, and comprehensive data packages, imaging results, and analysis reports are delivered.